Bioreactor Market Size Grows at CAGR of 12.1% & to Reach US$ 13.2 Billion by 2028

Published March 14, 2023

Bioreactor Market Overview 2023-2028:

IMARC Group’s latest research report, titled “Bioreactor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global bioreactor market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.2 Billion by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028. 

Bioreactor Uses:

Bioreactors are manufacturing devices in which biological reactions are executed and are used for organism's cultivation growth, such as mammalian cells, bacteria, yeast cells, and animal cells under controlled conditions.  They support a sustainable environment for cell growth and product formation.  These are mainly used in industrial processes for pharmaceutical products, including vaccines and monoclonal antibodies, among other products.  They are also widely utilized in industrial processes to cultivate organisms under controlled conditions and produce pharmaceutical products to treat chronic diseases.

Request Free Sample Report (Exclusive Offer on this report):

What is the Role of Bioreactor in Industry ? :

The global market is majorly driven by increasing demand for monoclonal antibiotics.  In line with this, rising funding from government and private organizations for vaccine development is significantly contributing to global market growth.  Furthermore, growing demand for single-use bioreactors; and rapid development in the pharmaceutical and biotechnology industry are positively influencing the market growth.  Apart from this, escalating Prevalence of several chronic conditions such as cardiovascular disorders, cancer, and diabetes is increasing the production of associated therapeutics, catalyzing the market expansion.  Moreover, increasing research and development activities to cater to efficient novel therapies in cancer treatment is propelling industry growth.  Besides, the growing demand for personalized medicine and shifting focus on orphan drug development is favoring the market growth.  Additionally, multiple market players are involved in developing advanced technology, such as inbuilt bioreactors with cost-effectiveness to deliver large-scale manufacturing, which will strengthen the product demand.

 Key Players Included in Global Bioreactor Market Research Report:

  • 2mag AG
  • bbi-biotech GmbH
  • Bioengineering AG
  • Eppendorf SE
  • Getinge AB
  • Infors AG
  • Merck KGaA
  • Pall Corporation (Danaher Corporation)
  • Sartorius AG
  • Solaris Biotechnology Srl 
  • Thermo Fisher Scientific Inc

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure:

Key Market Segmentation:

Breakup by Product Type:

  • Glass
  • Stainless Steel
  • Single-Use 

Breakup by Usage:

  • Lab-Scale Production
  • Pilot-Scale Production
  • Full-Scale Production 

Breakup by Scale:

  • 5L-20L
  • 20L-200L
  • 200L-1500L
  • Above 1500L 

Breakup by Control Type:

  • Manual
  • Automated

 Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report: 

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape 

Related Report By IMARC Group:

About Us: 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:


134 N 4th St. Brooklyn, NY 11249, USA


Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800